Dynamics in cardiometabolic risk among Turkish Adults: Similarities to that in Iranians?

International Journal of Preventive Medicine

Volumn 2, Issue 2, 2011, Pages 56-63

  Onat, Altan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Cardiometabolic risk factor; Ethnicity; Prediction; Prevention

Indexed keywords

APOLIPOPROTEIN A1; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CLASSIFICATION ALGORITHM; DISEASE SEVERITY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEART PROTECTION; HUMAN; IRAN; ISCHEMIC HEART DISEASE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; PREDICTION; PREVALENCE; PROTEIN FUNCTION; RACE DIFFERENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TURKEY (REPUBLIC);

EID: 79952726042     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome a new worldwide definition. Lancet 2005; 366(9491): 1059-62.
2. Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis 2001; 156(1): 1-10.
3. Onat A, Can G, Ayhan E, Kaya Z, Hergenc G. Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks. Metabolism 2009; 58(10): 1393-9.
4. Onat A, Can G, Cicek G, Dogan Y, Yuksel H. Coronary disease risk and fasting glucose levels in a nondiabetic population. Diabetes Res Clin Pract 2011.
5. Mahley RW, Palaoglu KE, Atak Z, Dawson-Pepin J, Langlois AM, Cheung V, et al. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995; 36(4): 839-59.
6. Hadaegh F, Khalili D, Fahimfar N, Tohidi M, Eskandari F, Azizi F. Glucose intolerance and risk of cardiovascular disease in Iranian men and women: results of the 7.6-year follow-up of the Tehran Lipid and Glucose Study (TLGS). J Endocrinol Invest 2009; 32(9): 724-30.
7. Tohidi M, Hatami M, Hadaegh F, Safarkhani M, Harati H, Azizi F. Lipid measures for prediction of incident cardiovascular disease in diabetic and nondiabetic adults: results of the 8.6 years follow-up of a population based cohort study. Lipids Health Dis 2010; 9:6.
8. Grundy SM, Brewer HB, Jr., Cleeman JI, Smith SC, Jr., Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 2004; 24(2): e13-8.
9. Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S, Can G. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis 2007; 191(1): 182-90.
10. Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S, Can G. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis 2007; 191(1): 182-90.
11. Hadaegh F, Shafiee G, Ghasemi A, Sarbakhsh P, Azizi F. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study. Diabetes Res Clin Pract 2010; 87(3): 342-7.
12. Kelishadi R, Sharifi M, Khosravi A, Adeli K. Relationship between C-reactive protein and atherosclerotic risk factors and oxidative stress markers among young persons 10-18 years old. Clin Chem 2007; 53(3): 456-64.
13. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26(11): 3160-7.
14. Onat A, Hergenc G, Uyarel H, Can G, Ozhan H. Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey. Anadolu Kardiyol Derg 2006; 6(4): 314-21.
15. Can G, Schwandt P, Onat A, Hergenç G, Heiss GM. Body fat, dyslipidemia, blood pressure and the effects of smoking in Germans and Turks. Turk J Med Sci 2009; 39:579-89.
16. Onat A, Ugur M, Can G, Yuksel H, Hergenc G. Visceral adipose tissue and body fat mass: predictive values for and role of gender in cardiometabolic risk among Turks. Nutrition 2010; 26(4): 382-9.
17. Onat A, Hergenc G, Keles I, Dogan Y, Turkmen S, Sansoy V. Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome. Metabolism 2005; 54(6): 800-8.
18. Esmailizadeh A, Azadbakht L. Increased levels of inflammation among women with enlarged waist and elevated triglyceride concentrations. Ann Nutr Metab 2010;57: 77-84.
19. Onat A, Can G, Hergenc G. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk. Metabolism 2008; 57(2): 207-14.
20. Onat A, Hergenc G, Can G, Kaya Z, Yuksel H. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population. Metabolism 2010; 59(5): 628-34.
21. Onat A, Hergenc G. Low-grade inflammation, and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk. Metabolism 2010.
22. Kelishadi R, Mirghaffari N, Poursafa P, Gidding SS. Lifestyle and environmental factors associated with inflammation, oxidative stress and insulin resistance in children. Atherosclerosis 2009; 203(1): 311-9.
23. Onat A, Hergenc G, Bulur S, Ugur M, Kucukdurmaz Z, Can G. The paradox of high apolipoprotein A-I levels independently predicting incident type-2 diabetes among Turks. Int J Cardiol 2010; 142(1): 72-9.
24. Onat A, Komurcu-Bayrak E, Can G, Kucukdurmaz Z, Hergenc G, Erginel-Unaltuna N. Apolipoprotein A-I positively associated with diabetes in women independently of apolipoprotein E genotype and apolipoprotein B levels. Nutrition 2010; 26(10): 975-80.
25. Ogasawara K, Mashiba S, Hashimoto H, Kojima S, Matsuno S, Takeya M, et al. Low-density lipoprotein (LDL), which includes apolipoprotein A-I (apoAI-LDL) as a novel marker of coronary artery disease. Clin Chim Acta 2008; 397(1-2): 42-7.
26. Onat A, Ozhan H, Erbilen E, Albayrak S, Kucukdurmaz Z, Can G, et al. Independent prediction of metabolic syndrome by plasma fibrinogen in men, and predictors of elevated levels. Int J Cardiol 2009; 135(2): 211-7.
27. Onat A, Hergenc G, Ayhan E, Ugur M, Kaya H, Tuncer M, et al. Serum apolipoprotein C-III in highdensity lipoprotein: a key diabetogenic risk factor in Turks. Diabet Med 2009; 26(10): 981-8.
28. Onat A, Ozhan H, Esen AM, Albayrak S, Karabulut A, Can G, et al. Prospective epidemiologic evidence of a protective effect of smoking on metabolic syndrome and diabetes among Turkish women--without associated overall health benefit. Atherosclerosis 2007; 193(2): 380-8.
29. Onat A, Can G, Yuksel H, Ayhan E, Dogan Y, Hergenc G. An algorithm to predict risk of type-2 diabetes in Turkish adults: contribution of C-reactive protein. J Endocrinol Invest 2010.
30. Onat A, Can G, Hergenç G, Uǧur M, Yüksel H. Coronary disease risk prediction algorithm warranting incorporation of C-reactive protein in Turkish adults, manifesting sex difference. Nutr Met CV Dis 2011. Availablefrom. URL:doi:10.1016/j.numecd.2010.10.010
31. Özkan J. Cardiology in Turkey comes of age after a decade of reforms and developments. Eur Heart J 2009; 30: 1022-4.